BILOPAQUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bilopaque, and what generic alternatives are available?
Bilopaque is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in BILOPAQUE is tyropanoate sodium. There is one drug master file entry for this compound. Additional details are available on the tyropanoate sodium profile page.
Summary for BILOPAQUE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Patent Applications: | 464 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BILOPAQUE at DailyMed |
US Patents and Regulatory Information for BILOPAQUE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | BILOPAQUE | tyropanoate sodium | CAPSULE;ORAL | 013731-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |